Cite
HARVARD Citation
Avallone, A. et al. (2016). A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme). BMC cancer. 16 (1), pp. 1-10. [Online].